---
symbol: "MRNA"
name: "Moderna"
date: 2026-10-09
change_pct: 14.74012049423056
direction: "up"
event_type: "other"
url: "https://perplo.app/why/MRNA/2026-10-09"
updated_at: 2026-10-09T23:06:44.540Z
---

# Why Moderna (MRNA) rose 14.74% on October 9, 2026

Moderna (MRNA) rose 14.74% on October 9, 2026 — Nasdaq-100 inclusion hopes and melanoma data fuel call.

## What happened

Moderna's options activity surged as traders piled into calls on hopes for Nasdaq-100 inclusion and on melanoma data expectations, pushing the stock up 13%.

## Why it moved

Call buying creates its own momentum: dealers hedge short-gamma exposure by buying shares, which amplifies the upside.

## Why it matters

Moderna is a high-beta name inside the Healthcare & Biotech theme, where prices are driven by pipeline catalysts rather than current earnings, so flow-driven spikes are common.

## What would break the thesis

If the Nasdaq-100 inclusion doesn't materialize or the melanoma data disappoints, the call-driven premium unwinds quickly.

## Sources

- [Moderna options activity surges as Nasdaq-100 inclusion and melanoma data drive call buying](https://www.investing.com/news/stock-market-news/moderna-options-activity-surges-as-nasdaq100-inclusion-and-melanoma-data-drive-call-buying-93CH-4941547) — Investing.com

---

Trade MRNA perpetual futures 24/7 onchain: https://perplo.app/asset/MRNA